Landec (Nasdaq: LNDC) reported earnings on Sep. 26. Here are the numbers you need to know.

The 10-second takeaway
For the quarter ended Aug. 26 (Q1), Landec beat expectations on revenues and beat expectations on earnings per share.

Compared to the prior-year quarter, revenue grew significantly and GAAP earnings per share expanded significantly.

Gross margins contracted, operating margins dropped, net margins were steady.

Revenue details
Landec logged revenue of $102.1 million. The four analysts polled by S&P Capital IQ foresaw a top line of $91.1 million on the same basis. GAAP reported sales were 39% higher than the prior-year quarter's $73.3 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
EPS came in at $0.10. The four earnings estimates compiled by S&P Capital IQ averaged $0.08 per share. GAAP EPS of $0.10 for Q1 were 43% higher than the prior-year quarter's $0.07 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
For the quarter, gross margin was 13.5%, 180 basis points worse than the prior-year quarter. Operating margin was 2.9%, 100 basis points worse than the prior-year quarter. Net margin was 2.5%, about the same as the prior-year quarter.

Looking ahead
Next quarter's average estimate for revenue is $110.7 million. On the bottom line, the average EPS estimate is $0.24.

Next year's average estimate for revenue is $416.1 million. The average EPS estimate is $0.64.

Investor sentiment
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 921 members out of 943 rating the stock outperform, and 22 members rating it underperform. Among 264 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 261 give Landec a green thumbs-up, and three give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Landec is buy, with an average price target of $11.25.